Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$5.22 - $10.44 $150,774 - $301,548
-28,884 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$9.5 - $13.75 $933,460 - $1.35 Million
-98,259 Reduced 77.28%
28,884 $306,000
Q2 2018

Aug 14, 2018

SELL
$12.85 - $18.45 $3.46 Million - $4.97 Million
-269,182 Reduced 67.92%
127,143 $1.72 Million
Q1 2018

May 15, 2018

BUY
$12.5 - $19.75 $417,912 - $660,301
33,433 Added 9.21%
396,325 $7.04 Million
Q4 2017

Feb 14, 2018

SELL
$11.55 - $20.1 $75,202 - $130,871
-6,511 Reduced 1.76%
362,892 $4.55 Million
Q3 2017

Nov 14, 2017

BUY
$12.7 - $19.25 $4.69 Million - $7.11 Million
369,403
369,403 $7.04 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.